We investigated indicative prognostic factors among serum tumor markers (CEA, NSE, SCCA and Cyfra21-1) and the clinical characteristics for NSCLC patients who underwent complete surgical resection of stage I, II and IIIA tumors. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.